Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc

Journal of Nutritional Biochemistry

Volumn 23, Issue 11, 2012, Pages 1458-1466

  Jansen, Judith ^a   Rosenkranz, Eva ^a   Overbeck, Silke ^a   Warmuth, Sabine ^a   Mocchegiani, Eugenio ^b   Giacconi, Robertina ^b   Weiskirchen, Ralf ^c   Karges, Wolfram ^a   Rink, Lothar ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b INRCA   (Italy)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Diabetes mellitus; Insulin signaling; Metallothionein; Single nucleotide polymorphism; Zinc; Zinc transporter

Indexed keywords

MESSENGER RNA; METALLOTHIONEIN 1A; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HOMEOSTASIS; HUMAN; IN VITRO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ZINC TRANSPORTER 5;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CELLS, CULTURED; CULTURE MEDIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INSULIN; LEUKOCYTES; LYMPHOCYTES; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; YOUNG ADULT; ZINC;

EID: 84867390002     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.09.008     Document Type: Article

References (65)

1. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev 1993, 73(1):79-118.
2. Prasad A.S. Zinc: an overview. Nutrition 1995, 11(1 Suppl):93-99.
3. Haase H., Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr 2009, 29:133-152.
4. Ibs K.H., Rink L. Zinc-altered immune function. J Nutr 2003, 133(5 Suppl 1):1452S-1456S.
5. Maret W., Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 2007, 13(7-8):371-375.
6. Rink L., Haase H. Zinc homeostasis and immunity. Trends Immunol 2007, 28(1):1-4.
7. Overbeck S., Uciechowski P., Ackland M.L., Ford D., Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol 2008, 83(2):368-380.
8. Mocchegiani E., Giacconi R., Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 2008, 14(10):419-428.
9. Lichten L.A., Cousins R.J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009, 29:153-176.
10. Rink L., Kirchner H. Zinc-altered immune function and cytokine production. J Nutr. 2000, 130(5S Suppl):1407S-1411S.
11. Costello L.C., Feng P., Milon B., Tan M., Franklin R.B. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 2004, 7(2):111-117.
12. Haase H., Overbeck S., Rink L. Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp Gerontol 2008, 43(5):394-408.
13. Jansen J., Karges W., Rink L. Zinc and diabetes - clinical links and molecular mechanisms. J Nutr Biochem 2009, 20(6):399-417.
14. Haase H., Ober-Blöbaum J.L., Engelhardt G., Hebel S., Heit A., Heine H., et al. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 2008, 181(9):6491-6502.
15. Lernmark A. Type 1 diabetes. Clin Chem 1999, 45(8 Pt 2):1331-1338.
16. Daneman D. Type 1 diabetes. Lancet 2006, 367(9513):847-858.
17. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104(43):17040-17045.
18. Lebovitz H.E. Type 2 diabetes: an overview. Clin Chem 1999, 45(8 Pt 2):1339-1345.
19. Seshasai S.R., Kaptoge S., Thompson A., Di Angelantonio E., Gao P., Sarwar N., et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364(9):829-841.
20. McNair P., Kiilerich S., Christiansen C., Christensen M.S., Madsbad S., Transbol I. Hyperzincuria in insulin treated diabetes mellitus - its relation to glucose homeostasis and insulin administration. Clin Chim Acta 1981, 112(3):343-348.
21. Kinlaw W.B., Levine A.S., Morley J.E., Silvis S.E., Mc Clain C.J. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983, 75(2):273-277.
22. Canfield W.K., Hambidge K.M., Johnson L.K. Zinc nutriture in type I diabetes mellitus: relationship to growth measures and metabolic control. J Pediatr Gastroenterol Nutr 1984, 3(4):577-584.
23. Kiilerich S., Hvid-Jacobsen K., Vaag A., Sørensen S.S. 65 zinc absorption in patients with insulin-dependent diabetes mellitus assessed by whole-body counting technique. Clin Chim Acta 1990, 189(1):13-18.
24. Pai L.H., Prasad A.S. Cellular zinc in patients with diabetes mellitus. Nutrition Research 1988, 8:889-897.
25. Williams N.R., Rajput-Williams J., West J.A., Nigdikar S.V., Foote J.W., Howard A.N. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus. Analyst 1995, 120(3):887-890.
26. Aguilar M.V., Saavedra P., Arrieta F.J., Mateos C.J., González M.J., Meseguer I., et al. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007, 51(5):402-406.
27. Davies I.J., Musa M., Dormandy T.L. Measurements of plasma zinc. I. In health and disease. J Clin Pathol 1968, 21(3):359-363.
28. Zargar A.H., Bashir M.I., Masoodi S.R., Laway B.A., Wani A.I., Khan A.R., et al. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J 2002, 23(5):539-542.
29. Kruse-Jarres J.D., Rükgauer M. Trace elements in diabetes mellitus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol 2000, 14(1):21-27.
30. Meftah S., Prasad A.S., Lee D.Y., Brewer G.J. Ecto 5' nucleotidase (5'NT) as a sensitive indicator of human zinc deficiency. J Lab Clin Med 1991, 118(4):309-316.
31. Blostein-Fujii A., DiSilvestro R.A., Frid D., Katz C., Malarkey W. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr 1997, 66(3):639-642.
32. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85(3):837-844.
33. Kahmann L., Uciechowski P., Warmuth S., Plümäkers B., Gressner A.M., Malavolta M., et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008, 11(1):227-237.
34. Devirgiliis C., Zalewski P.D., Perozzi G., Murgia C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007, 622(1-2):84-93.
35. Chimienti F., Devergnas S., Favier A., Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004, 53(9):2330-2337.
36. Chimienti F., Devergnas S., Pattou F., Schuit F., Garcia-Cuenca R., Vandewalle B., et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006, 119(Pt 20):4199-4206.
37. Chausmer A.B. Zinc, insulin and diabetes. J Am Coll Nutr 1998, 17(2):109-115.
38. Dodson G., Steiner D. The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 1998, 8(2):189-194.
39. Lemaire K., Ravier M.A., Schraenen A., Creemers J.W., Van de Plas R., Granvik M., et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci U S A 2009, 106(35):14872-14877.
40. Nicolson T.J., Bellomo E.A., Wijesekara N., Loder M.K., Baldwin J.M., Gyulkhandanyan A.V., et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009, 58(9):2070-2083.
41. Fu Y., Tian W., Pratt E.B., Dirling L.B., Shyng S.L., Meshul C.K., et al. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS One 2009, 4(5):e5679.
42. Pound L.D., Sarkar S.A., Benninger R.K., Wang Y., Suwanichkul A., Shadoan M.K., et al. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J 2009, 421(3):371-376.
43. Smidt K., Pedersen S.B., Brock B., Schmitz O., Fisker S., Bendix J., et al. Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol 2007, 264(1-2):68-73.
44. Murgia C., Devirgiliis C., Mancini E., Donadel G., Zalewski P., Perozzi G. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutr Metab Cardiovasc Dis 2009, 19(6):431-439.
45. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316(5829):1341-1345.
46. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885.
47. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316(5829):1336-1341.
48. Cauchi S., Meyre D., Durand E., Proença C., Marre M., Hadjadj S., et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE 2008, 3(5):e2031.
49. Staiger H., Machicao F., Stefan N., Tschritter O., Thamer C., Kantartzis K., et al. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS ONE 2007, 2(9):e832.
50. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39(6):770-775.
51. Boesgaard T.W., Zilinskaite J., Vänttinen M., Laakso M., Jansson P.A., Hammarstedt A., et al. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients - the EUGENE2 study. Diabetologia 2008, 51(5):816-820.
52. Giacconi R., Bonfigli A.R., Testa R., Sirolla C., Cipriano C., Marra M., et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab 2008, 94(1):98-104.
53. Yang L., Li H., Yu T., Zhao H., Cherian M.G., Cai L., et al. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab 2008, 294(5):E987-E992.
54. Raptopoulou M., Goulis G. Physiological variations of T cells during the menstrual cycle. Clin Exp Immunol 1977, 28(3):458-460.
55. McBean L., Halsted J.A. Fasting versus postprandial plasma zinc levels. J Clin Pathol 1969, 22(5):623.
56. Faneyte I.F., Kristel P.M., van de Vijver M.J. Determining MDR1/P-glycoprotein expression in breast cancer. Int J Cancer 2001, 93(1):114-122.
57. Haase H., Hebel S., Engelhardt G., Rink L. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal Biochem 2006, 352(2):222-230.
58. Haase H., Mocchegiani E., Rink L. Correlation between zinc status and immune function in the elderly. Biogerontology 2006, 7(5-6):421-428.
59. Tamaki M., Fujitani Y., Uchida T., Hirose T., Kawamori R., Watada H. Downregulation of ZnT8 expression in pancreatic β-cells of diabetic mice. Islets 2009, 1(2):124-128.
60. Wijesekara N., Dai F.F., Hardy A.B., Giglou P.R., Bhattacharjee A., Koshkin V., et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 2010, 53(8):1656-1668.
61. Prasad A.S., Meftah S., Abdallah J., Kaplan J., Brewer G.J., Bach J.F., et al. Serum thymulin in human zinc deficiency. J Clin Invest 1988, 82(4):1202-1210.
62. Lill N. Insulin formulations. Pharm Unserer Zeit 2001, 30(1):56-62.
63. Lee S., Chanoit G., McIntosh R., Zvara D.A., Xu Z. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol 2009, 297(2):H569-H575.
64. Rink L., Gabriel P. Extracellular and immunological actions of zinc. Biometals 2001, 14(3-4):367-383.
65. Von Bülow V., Rink L., Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate. J Immunol 2005, 175(7):4697-4705.